Acquisitions over the past year powered isotope technology developer Eckert & Ziegler to 8% sales growth in the company's second quarter (end-1 June).
Sales advanced to 31.2 million euros ($41.5 million U.S.), compared with 28.8 million euros ($38.3 million U.S.) in the second quarter of 2014. Net income, however, decreased to 1.7 million euros ($2.3 million U.S.) in the quarter, compared with 3 million euros ($4 million U.S.) in last year's second quarter.
For the six-month period, sales rose by 12%, to 61.9 million euros ($82.3 million U.S.), compared with 55.3 million euros ($73.5 million U.S.) in the first half year of 2013. Net income declined to 3.2 million euros ($4.2 million U.S.), compared with 4.7 million euros ($6.2 million U.S.) in the year-ago period.
The company also reaffirmed its forecast of 134 million euros ($178 million U.S.) in sales for all of 2014.
